Stx1 — Syntaxin 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Syntaxin-1 is a t-SNARE (target SNARE) protein essential for synaptic vesicle fusion. It partners with SNAP-25 and VAMP2 to form the ternary SNARE complex that mediates neurotransmitter release at the presynaptic terminal.
Syntaxin-1 is a 35 kDa transmembrane protein localized to the presynaptic plasma membrane. It is one of the key components of the synaptic vesicle release machinery and is essential for fast synaptic transmission.
| Attribute | Value |
|---|---|
| Gene Symbol | STX1A |
| Chromosomal Location | 7q11.23 |
| Protein Name | Syntaxin-1A |
| UniProt | P61266 |
| Molecular Weight | 35 kDa |
Syntaxin-1 contains:
Syntaxin-1 mediates:
Botulinum neurotoxin C targets syntaxin-1 for therapeutic muscle relaxation in dystonia and spasticity.
The study of Stx1 — Syntaxin 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Botulinum neurotoxin C (BoNT/C) specifically cleaves syntaxin-1 at the neuronal plasma membrane:
Syntaxin-1 plays a crucial role in synaptic homeostasis:
Altered syntaxin-1 function is observed in:
Syntaxin-1 interacts with numerous synaptic proteins:
| Partner | Interaction Type | Function |
|---|---|---|
| SNAP-25 | SNARE complex | Membrane fusion |
| VAMP2 | SNARE complex | Vesicle docking |
| Munc18 | Binding | Syntaxin chaperone |
| Munc13 | Binding | Vesicle priming |
| RIM | Binding | Active zone organization |
| Synaptotagmin-1 | Calcium sensing | Fusion trigger |
Syntaxin-1 modulators are being investigated for:
Multiple syntaxin-1 isoforms exist:
Syntaxin-1 is a central player in synaptic vesicle fusion, forming the t-SNARE component of the SNARE complex. Its dysfunction contributes to multiple neurological disorders, making it both a therapeutic target and a potential biomarker.